Advertisement

Topics

Marcum Cronus Partners Company Profile

12:56 EST 12th December 2017 | BioPortfolio

Advising on mergers, acquisitions, divestitures, sales, and private placement financings, Marcum Cronus Partners is an investment banking firm that provides financial advisory and other investment banking services. The clients of the firm are publicly traded or privately owned companies that engage in middle-market transactions domestically or internationally. Winner of the Association for Corporate Growth’s 2012 Boutique Investment Bank of the Year Award, Marcum Cronus is an affiliate of Marcum LLP, one of the largest independent public accounting and advisory services firms in the U.S. (with 23 offices and more than 1,100 professionals). To learn more, please visit www.MarcumCronus.com.


News Articles [106 Associated News Articles listed on BioPortfolio]

Evariant Named Recipient of Marcum Tech Top 40 Award as one of Connecticut’s Fastest Growing Tech Companies

The Connecticut Technology Council (CTC) and Marcum LLP announced Evariant, the leading healthcare CRM data analytics platform, has made the Marcum Tech Top 40 (TT40) list of fast...

NutraScience Labs “Runs for a Reason” During The 2017 Marcum Workplace Challenge

The annual run-walk event was held at Jones Beach State Park and raised funds for four Long Island-based charitable organizations. Farmingdale, New York (PRWEB) July 27, 2017 NutraScience Labs, the e...

Managing post-amputation pain with neurostimulation, Neuros Medical raises $20M

U.S. Venture Partners led the round with participation from Boston Scientific, Aperture Venture Partners, Osage University Partners, and JumpStart.

Partners Healthcare Closed $171M Innovation Fund for Life Sciences Startups

Partners HealthCare System has closed a $171 million innovation fund to invest in early stage life sciences startups. The innovation fund includes $66.1 million in outside capital for Partners Innovat...

Partners HealthCare raises $171M for second innovation fund for healthcare startups (Updated)

Partners Innovation Fund II will invest in 15-20 companies, according to Roger Kitterman, Vice President of Partners Innovation. It will be particularly aggressive in gene therapy.

MorphoSys-Aktie: Shortseller AHL Partners attackiert weiterhin! Aktiennews

Martinsried - Leerverkäufer AHL Partners LLP stockt Netto-Leerverkaufsposition in MorphoSys-Aktien stark auf: Die Leerverkäufer von AHL Partners LLP attackieren die Aktien des Biotech-Unternehmens ....

MorphoSys-Aktie: Shortseller AHL Partners zieht sich weiterhin zurück - Aktiennews

Martinsried - Leerverkäufer AHL Partners LLP baut Netto-Leerverkaufsposition in MorphoSys-Aktien signifikant ab: Die Leerverkäufer von AHL Partners LLP haben sich aus ihrem Short-Engagement in den ....

Evotec-Aktie bleibt unter Beschuss von Leerverkäufer AHL Partners! Aktiennews

Hamburg - Leerverkäufer AHL Partners LLP stockt Netto-Leerverkaufsposition in Aktien der Evotec AG weiter sichtbar auf: Die Leerverkäufer von AHL Partners LLP befinden sich kontinuierlich im Attack....

Drugs and Medications [21 Associated Drugs and Medications listed on BioPortfolio]

Sweatblock [DC Alpine Partners, LLC DBA: Sweatblock]

SWEATBLOCK Clinical Strength Antiperspirant

Day cream mattifying hydrator [MOSAIC MARKETING PARTNERS LLC]

DAY CREAM MATTIFYING HYDRATOR

Ribavirin [Sandoz Inc]

These highlights do not include all the information needed to use RIBAVIRIN TABLETS safely and effectively. See full prescribing information for RIBAVIRIN TABLETS. Ribavirin Tablets, oralInitial U.S. ...

Ribavirin [Cadila Healthcare Limited]

These highlights do not include all the information needed to use ribavirin safely and effectively. See full prescribing information for ribavirin. Initial U.S. Approval: 2002

Ribavirin [Zydus Pharmaceuticals (USA) Inc.]

These highlights do not include all the information needed to use ribavirin safely and effectively. See full prescribing information for ribavirin. Initial U.S. Approval: 2002

PubMed Articles [241 Associated PubMed Articles listed on BioPortfolio]

Partners' Overestimation of Patients' Pain Severity: Relationships with Partners' Interpersonal Responses.

The present study examined whether concordance between patients' and their partners' reports of patient pain severity relates to partners' social support and behavioral responses in couples coping wit...

Psychological distress in men with prostate cancer and their partners before and after cancer diagnosis: a longitudinal study.

To examine the relative risk of psychological distress of men with prostate cancer and their partners during the period before and after prostate cancer diagnosis compared with men without prostate ca...

Partners of nulliparous women with severe fear of childbirth: A longitudinal study of psychological well-being.

Little is known about the psychological status of partners of women with severe fear of childbirth (FOC). In this longitudinal study from Helsinki University Central Hospital, we investigated FOC, dep...

A Qualitative Study of Means to Improve Partner Notification After an HIV Diagnosis Among Men Who Have Sex with Men in Australia.

Improved partner notification (PN) after HIV diagnosis could help control HIV among men who have sex with men (MSM). However, there is little evidence exploring what this experience is like for Austra...

Predictors of Patient and Partner Satisfaction Following Radical Prostatectomy.

The diagnosis and treatment of prostate cancer adversely affects the physical and emotional well-being of patients and partners and has been associated with sexual dysfunction in patients and their in...

Clinical Trials [250 Associated Clinical Trials listed on BioPortfolio]

Study to Evaluate the Safety of Cronus® - Cobalt Chromium Coronary Stent

The objective this study is evaluate the performance and safety of Chronus® cobalt-chromium coronary stent in patients with "de novo" native coronary artery lesions treated with 19-mm-lon...

Partners Demonstration Project of PrEP and ART

The purpose of this protocol is to determine user preferences for antiretroviral therapy (ART) for HIV-1 infected partners and pre-exposure prophylaxis (PrEP) HIV-1 un-infected partners an...

Teachers and Parents as Partners During Middle School

There are two aims of this study (a) to examine the effect of Teachers and Parents as Partners on student, parent, and teacher outcomes in middle school and (b) identify barriers and facil...

Treatment for Men Who Are Abusive to Their Partners

This study will develop an individual behavior therapy for men who are violent toward their partners and will compare the therapy to standard group treatment.

Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners

This pilot clinical trial studies how well acceptance and commitment therapy works in improving well-being in patients with stage III-IV cancer and their partners. Learning how to accept n...

Companies [891 Associated Companies listed on BioPortfolio]

Marcum Cronus Partners

Advising on mergers, acquisitions, divestitures, sales, and private placement financings, Marcum Cronus Partners is an investment banking firm that provides financial advisory and...

SageCreek Partners

SageCreek Partners is creating and driving a new category of service: Mentor Capital. Working as a companion to technology companies and their investment partners and boards, Sage...

Health Partners Plans (HPP)

Nationally recognized for its innovations in managed care, Health Partners Plans consistently receives the highest ratings for member and provider satisfaction and, is currently r...

Prospect Partners, LLC

Prospect Partners is a leading private equity firm investing in smaller lower-middle-market companies, managing $470 million across three funds. A highly experienced and active in...

Vista Partners

With offices in California and Oregon, Vista Partners LLC is one of the fastest growing independently owned equity research and consulting firms in the United States. Vista Partners professional staff...

More Information about "Marcum Cronus Partners" on BioPortfolio

We have published hundreds of Marcum Cronus Partners news stories on BioPortfolio along with dozens of Marcum Cronus Partners Clinical Trials and PubMed Articles about Marcum Cronus Partners for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Marcum Cronus Partners Companies in our database. You can also find out about relevant Marcum Cronus Partners Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record